Mark Lackner, Chief Scientific Officer: Zentalis Pharmaceuticals ZNTL Sell · Filed 25/01/03

Trade details

Type: Insider sale
Amount: $13,762.32
Shares · price: 4,411 sh · $3.12 a share
Held after: 191,317 sh
Stock: Zentalis Pharmaceuticals ZNTL
Person: Mark LacknerChief Scientific Officer
Trade date: 25/01/02
Filed: 25/01/03
Days to filing: 1 days

Sold 2.3% of holdings

Share of holding sold: 2.3%

Zentalis Pharmaceuticals trades, last 26 weeks

What else happened in Zentalis Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/12/03~25/02/01

Mark Lackner's recent trades

Mark LacknerChief Scientific Officer
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$24.6K
14,368 sh
$24.6K
Filed 25/02/05
Traded 25/02/03
Lackner MarkChief Scientific Officer
Planned saleZentalis Pharmaceuticals
Planned sale
Zentalis Pharmaceuticals
ZNTL
$24.6K
14,368 sh
$24.6K
Filed 25/02/03
Traded 25/02/03
Mark LacknerChief Scientific Officer
SellZentalis Pharmaceuticals
Sell
Zentalis Pharmaceuticals
ZNTL
$18.3K
1,585 sh
$18.3K
Filed 24/02/05
Traded 24/02/02